1 1
COVID-19

Jant Pharmacal

Flowflex COVID-19 Antigen Home Test - 1 Test/Box (IDL031118B5)

Flowflex COVID-19 Antigen Home Test - 1 Test/Box (IDL031118B5)

$6.65 USD
$6.65 USD
Sale Sold out

⚠️ Back Order Estimated Restock Date:

Item Number

IDL031118B5

Order Packaging

1 Each (1 Test/Box)

Vendor Shipping & Returns

Jant Pharmacal Shipping:
Minimum Order $50.00. Free shipping orders over $800.00 on regular priced items. $15.00 flat rate shipping GND (1-5 BUS DAYS) in continental USA. Exclusions may apply.

Jant Pharmacal Returns:
15% restocking fee, 10% administration fee. Shipping is paid for by the customer. Original packaging. No returns after 30 days.Not all products are eligible for returns. Exclusions may apply. All returns must be approved by our Returns Department. An e-mail notification will be issued regarding your return status and return instructions, should this apply. Any product returned for credit without an authorized RMA number clearly printed on the outside package or shipping label will be refused. Unauthorized returns will not be honored or accepted for credit.

View full details

Flowflex COVID-19 Antigen Home Test is a rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection. For self-testing use. For use under an Emergency Use Authorization (EUA) only.

FDA UPDATE:

FDA has granted 510(k) clearance for Flowflex and becomes the first FDA 510(k) for an OTC rapid antigen Covid test! The 510(k) version of Flowflex will be produced domestically.

OMICRON UPDATE: Does Flowflex Detect Omicron?

An independent evaluation conducted by the National Institutes of Health’s (NIH) RADx program has indicated that the Flowflex™ COVID-19 Antigen Home Test does detect the Omicron subvariant BA.1 and BA.2 in live clinical samples.

Clinical Performance:

The performance of Flowflex COVID-19 Antigen Home Test was established in an all-comers clinical study conducted between March 2021 and May 2021 with 172 nasal swabs self-collected or pair-collected by another study participant from 108 individual symptomatic patients (within 7 days of onset) suspected of COVID-19 and 64 asymptomatic patients. The Flowflex COVID-19 Antigen Home Test results were compared to an FDA EUA RT-PCR COVID-19 assay to determine test performance in the table below:

Flowflex COVID-19 Antigen Home Test

 RT-PCR method
Positive Negative Total
Positive 39 0 39
Negative 3 130 133
Total 42 130 172
Positive Percent Agreement (PPA) 93% (95% CI: 81% -99%)
Negative Percent Agreement (NPA) 100% (95% CI: 97% – 100%)

Analytical Sensitivity: Limit of Detection (LoD): LoD was determined as the lowest virus concentration that was detected ≥ 95% of the time. Based on this testing, the LoD in nasal matrix was confirmed to be 2.5 x 103 TCID50/mL

Flowflex COVID-19 Antigen Home Test

PRODUCT DETAILS

Catalog Number Description Units of Measurements
IDL031118B5 Flowflex® COVID-19 Antigen Home Test  1 Test/Kit
IDL031125M5 Flowflex® COVID-19 Antigen Home Test  2 Tests/Kit
IDL031125P5 Flowflex® COVID-19 Antigen Home Test  25 Tests/Kit